Iron Deficiency and Hair Loss: What Ferritin Thresholds Actually Mean
Iron deficiency is one of the most commonly identified nutritional abnormalities in hair loss workups, particularly in premenopausal women. The association between low ferritin levels and diffuse hair loss — especially telogen effluvium and female pattern hair loss — is well-established in observational studies. The clinical question is more nuanced: what ferritin threshold warrants intervention, does iron supplementation improve hair loss outcomes, and how does iron deficiency interact with other hair loss causes?
The supplement industry has amplified the iron-hair loss association into broad claims about iron supplementation for hair growth, often without the ferritin-threshold nuance that makes the clinical evidence meaningful. Understanding what the evidence actually shows — and what it doesn't — is important for both clinicians and patients navigating the hair loss supplement market.
This analysis reviews the mechanistic evidence for iron's role in hair cycling, the observational data on ferritin and hair loss, the ferritin threshold debate, and the limited intervention trial evidence for iron supplementation in hair loss.
Iron's Role in Hair Cycling: The Mechanistic Evidence
Iron is required for multiple cellular processes relevant to hair growth. Most importantly, iron is a cofactor for ribonucleotide reductase — the rate-limiting enzyme in DNA synthesis — making it essential for the rapid cell division that occurs in the hair matrix during the anagen phase. Hair follicle matrix cells are among the most rapidly dividing cells in the body, making them particularly sensitive to iron availability.
Iron is also required for mitochondrial function (as a component of cytochrome c oxidase and other electron transport chain proteins) and for the activity of several enzymes involved in collagen synthesis and keratin production. The mechanistic rationale for iron deficiency impairing hair growth is therefore well-grounded in cell biology.
Ferritin — the primary iron storage protein — is the most sensitive marker of iron depletion, falling before hemoglobin or serum iron become abnormal. This is why ferritin is the preferred marker for hair loss workups: patients can have iron-depleted stores (low ferritin) with normal hemoglobin and serum iron, and this subclinical iron depletion may be sufficient to impair hair growth.
The Claim
"Iron deficiency is one of the most common and overlooked causes of hair loss in women. Getting your ferritin tested and supplementing to optimal levels can dramatically reduce shedding and restore hair density — especially for diffuse thinning and telogen effluvium."
(Composite representative claim reflecting iron supplement marketing and wellness content targeting hair loss.)
What the Evidence Actually Shows
The observational evidence linking low ferritin to hair loss is consistent. Multiple cross-sectional studies have found lower mean ferritin levels in women with telogen effluvium and female pattern hair loss compared to controls. A 2006 study by Rushton found that 72% of women with chronic diffuse telogen hair loss had ferritin levels below 40 ng/mL, compared to 32% of controls. The association is stronger for TE than for androgenetic alopecia.
The ferritin threshold for intervention is genuinely debated. Standard laboratory reference ranges define deficiency as ferritin below 12–15 ng/mL. However, several hair loss specialists recommend intervention at ferritin below 30–70 ng/mL in the context of hair loss, based on the observation that hair loss patients with ferritin in the 15–40 ng/mL range may respond to iron supplementation. This higher threshold is not universally accepted and is not based on RCT evidence.
The intervention evidence is limited. A 2006 RCT by Rushton and colleagues (n=30) found that iron supplementation in women with TE and ferritin below 40 ng/mL produced significant improvement in hair loss scores versus placebo. This is the most-cited intervention trial, but it is small and has not been independently replicated. The "dramatically reduces shedding" claim overstates what a single small trial supports.
Clinical Implications: Testing, Thresholds, and Supplementation
The evidence supports ferritin testing as part of a hair loss workup in women with diffuse thinning or TE. Correction of documented iron deficiency (ferritin below 12–15 ng/mL by standard criteria) is appropriate regardless of hair loss status. For hair loss patients with ferritin in the 15–40 ng/mL range, a trial of iron supplementation is reasonable given the limited intervention evidence and favorable safety profile of oral iron at standard doses.
The response to iron supplementation for hair loss, when it occurs, is typically slow — 3–6 months of supplementation may be required before hair loss improvement is apparent. This timeline is important for patient counseling and adherence. Iron supplementation should be accompanied by monitoring of ferritin levels to confirm repletion and avoid iron overload.
Verdict: Partially Supported
The association between iron deficiency and hair loss is well-established in observational studies, and the mechanistic rationale is sound. The intervention evidence — one small RCT showing improvement with iron supplementation in ferritin-deficient women with TE — is positive but limited. The ferritin threshold for intervention in hair loss patients is debated and not established by RCT evidence. The "dramatically reduces shedding" claim overstates the evidence. Ferritin testing and correction of documented deficiency are appropriate; supplementation in iron-sufficient individuals is not evidence-supported. Evidence rating: 3/5.